These studies uniformly showed that Liraglutide significantly reduced body weight when used as an adjunct therapy with diet and exercise
GLP-1RAs The natural ligand, GLP-1, is a 30-amino-acid incretin peptide secreted by intestinal L cells, effectively stimulating glucose-dependent insulin secretion, inhibiting glucagon release, slowing gastric emptying, and promoting satiety [62,63,64]
The concentration appears as a ratio, usually formatted as milligrams per milliliter
Gogineni P, Melson E, Papamargaritis D, Davies M
the cohort included 13,204 GLP-1 RA users and 13,204 nonusers.The researchers observed associations for GLP-1 RA use with lower risks for stroke/transient ischemic attack, pulmonary embolism, venous thromboembolism, emergency department visits, and mortality (hazard ratios, 0.87, 0.69, 0.83, 0.79, and 0.56, respectively)."As an obesity medicine physician scientist who regularly cares for patients with complex inflammatory conditions, this study reinforces what many of us have suspected clinically -- that the benefits of GLP-1 receptor agonists extend well beyond blood sugar control and weight loss and may fundamentally alter the disease trajectory for some of our highest-risk patients," Fatima Cody Stanford, M.D., M.P.H., member of the American Heart Association Lifestyle and Cardiometabolic Council, said in a statement.Abstract/Full TextMore Information.Sign up for our weekly HealthDay newsletter
